Peptide Therapeutics is the fastest growing segment fueling growth of the Peptide Therapeutics Market
The global Peptide Therapeutics Market is estimated to be valued at US$ 44,386.9 Mn in 2023 and is expected to exhibit a CAGR of 6.6% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market Overview:
Peptide therapeutics are short chains of amino acids linked by peptide (amide)
bonds. They can be used as alternatives to conventional small molecule drugs
due to their high potency, specificity and low toxicity. They are used to treat
conditions such as cancer, metabolic disorders, cardiovascular diseases etc.
Market key trends:
One of the key trends in the peptide
therapeutics market size is the rising investment in R&D of novel
peptide drugs. Peptide-based drugs have advantages over small molecules such as
higher target specificity and lower toxicity. Major players are investing
heavily in development of novel peptide drugs for various indications. For
instance, Amgen invested around $5 billion in 2019 on R&D activities including
development of novel peptide drugs for conditions such as cancer and
cardiovascular diseases. In addition, development of optimized drug delivery
methods for peptides is also accelerating the market growth. New technologies
such as nanoparticle formulations are being developed to enhance stability,
bioavailability and half-life of peptide drugs.
Segment Analysis
Peptide therapeutics market is segmented into proprietary peptides, generic
peptides, and drug delivery systems. The proprietary peptides segment dominates
the market and accounts for around 60% market share due to the prevalence of
clinically validated peptides and rising adoption of proprietary peptides to
address specific disease conditions.
Key Takeaways
The global peptide therapeutics market is expected to witness high growth,
exhibiting a CAGR of 6.6% over the forecast period, due to increasing R&D
investments by key players and rising prevalence of metabolic and
gastrointestinal disorders.
Regional Analysis
North America dominates the global peptide therapeutics market and is expected
to continue its dominance over the forecast period. This is attributed to the
advanced healthcare infrastructure and rising incidence of chronic diseases in
the region. Asia Pacific exhibits the fastest growth due to increasing
healthcare spending and presence of huge patient population.
Key players
Key players operating in the peptide therapeutics market are Teva
Pharmaceutical Industries Ltd, Novo Nordisk A/S, OPKO Health Inc., Lilly, Hanmi
Pharm.Co., Sanofi, Circle Pharma, Pfizer Inc., Novartis AG, PeptiDream Inc.,
Amgen Inc., AstraZeneca, Bachem Holding AG, CordenPharma International, Ipsen
Pharma, Merck KGaA, PolyPeptide Group, Bayer AG.
Get
more insights on this topic: https://www.newsstatix.com/peptide-therapeutics-market-share-and-opportunity-analysis-2023-2030/
Comments
Post a Comment